Inebilizumab for Myasthenia Gravis Reduces Steroid Burden

(MedPage Today) -- Data from the randomized MINT trial, presented at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting, showed that the anti-CD19 monoclonal antibody inebilizumab (Uplizna) for generalized...